| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10070651 | European Journal of Surgical Oncology (EJSO) | 2005 | 7 Pages |
Abstract
Complete tumour resection following secondary cytoreductive surgery is associated with improved survival in selected groups of patients with recurrent ovarian cancer. However, other clinical factors than surgical cytoreduction are of considerable significance in determining the outcome of the salvage treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
B. Gronlund, L. Lundvall, I.J. Christensen, J.B. Knudsen, C. Høgdall,